Dr Chris Van Tulleken calls on the British public to seek out the truth about the top-selling over-the-counter medicines. We spend an astonishing 2.3 billion pounds on pills, potions and lotions from the chemist's shop every year to beat common ailments from headaches to colds to indigestion. But how much do we really know about what we're buying?
We bring you a special episode, celebrating the award of this year's Nobel Prize in Physiology or Medicine to Tasuku Honjo, Distinguished Professor at Kyoto University. His basic research has led to the development and clinical applications of Opdivo, a groundbreaking new anti-cancer drug that works with immune cells. It has given hope to many cancer patients, and surprised clinical specialists. We'll explore what innovation Opdivo has brought to cancer treatment, and what challenges remain.